|
|
|
|
|
|
 |
|
|
|
 |
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
If you ever thought that NATURAL, potent, pain relief was
light years away...THINK AGAIN
|
|
|
|
Celecaine™ Soft Gels use cutting edge technology to promote joint
flexibility, mobility and overall joint health.
An independent double-blind, placebo controlled, randomized, multi-
center clinical study found gel capsules to be significantly effective in
promoting joint flexibility and mobility. In the study, Celecaine™ gel
capsules significantly increased joint flexibility, flat ground walking,
traversing up and down stairs, range of motion and overall quality of life,
with no side effects reported.
The results have been peer reviewed and published in one of the world’
s leading medical journals, The Journal of Rheumatology, J Rheumatology
2002;29:1708-12. During the 68 day study period of patients,
participants were evaluated by physicians, who performed clinical
assessments for levels of pain, flexion, joint changes, range of motion
and physical activity.
The Journal of Rheumatology study also concluded that the gel
capsules may be an alternative to the use of nonsteroidal anti-
inflammatory drugs.
Studies of the product formula in pill form have also been presented
at international scientific forums, reporting its efficacy, bioavailability
and safety.
Promotes and supports healthy joint function and mobility on an
internal basis and throughout the body.
Promotes joint flexibility, improves range of motion and provides a
cumulative benefit.
Promotes an overall improvement in one's Quality of Life.
Celecaine™ soft gels have been clinically tested for
safety and efficacy with no known side effects.
|
|
|
|
|
|
|
|
 |
|
|
|
CELECAINE Gel Caps Ingredients
|
|
|
Serving Size: 3 Soft Gels
Servings per Container: 40
|
|
|
|
Ingredient Amount per serving % Daily Value
|
|
|
Celecaine™ (Proprietary 1500 mg -
Blend of Fatty Acid Esters)
Other Ingredients: Soy Lecithin and Fish Oil
As a dietary supplement take 3 to 6 gel caps per day with an 8 oz glass
of water.
|
|
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
| |
|
